Search

Your search keyword '"Marelli, Ariane"' showing total 147 results

Search Constraints

Start Over You searched for: Author "Marelli, Ariane" Remove constraint Author: "Marelli, Ariane" Database MEDLINE Remove constraint Database: MEDLINE
147 results on '"Marelli, Ariane"'

Search Results

1. Fontan circulation and systemic disease - a retrospective cohort analysis over 35 years of follow-up: Fontan systemic disease at 35 years.

2. Development of MyREADY Transition BBD Mobile App, a Health Intervention Technology Platform, to Improve Care Transition for Youth With Brain-Based Disabilities: User-Centered Design Approach.

3. Risk of cardiovascular events after influenza infection-related hospitalizations in adults with congenital heart disease: A nationwide population based study.

4. Outcomes After Pediatric Pulmonary Valve Replacement in Patients With Tetralogy of Fallot.

5. Clinical Risk Assessment and Prediction in Congenital Heart Disease Across the Lifespan: JACC Scientific Statement.

6. MixEHR-SurG: A joint proportional hazard and guided topic model for inferring mortality-associated topics from electronic health records.

7. hART: Deep learning-informed lifespan heart failure risk trajectories.

8. Determinants and Clinical Outcomes of Patients With Tetralogy of Fallot Lost to Cardiology Follow-up.

9. Navigating meaningful engagement: lessons from partnering with youth and families in brain-based disability research.

10. CanCHD Study of Hematopoietic Cancers in Children With and Without Genetic Syndromes.

11. Adult Congenital Heart Disease Care in Canada: Has Quality of Care Improved in the Last Decade?

12. Machine Learning Informed Diagnosis for Congenital Heart Disease in Large Claims Data Source.

13. A commentary on the healthcare transition policy landscape for youth with disabilities or chronic health conditions, the need for an inclusive and equitable approach, and recommendations for change in Canada.

14. Tetralogy of Fallot Across the Lifespan: A Focus on the Right Ventricle.

15. Severe Fontan-Associated Liver Disease and Its Association With Mortality.

16. The Impact of the COVID-19 Pandemic Restrictions on the Provision of Adult Congenital Heart Disease Care Across Canada: A National Survey.

18. Changing epidemiology of congenital heart disease: effect on outcomes and quality of care in adults.

19. Artificial Intelligence in Congenital Heart Disease: Current State and Prospects.

20. Management of Heart Failure With Arrhythmia in Adults With Congenital Heart Disease: JACC State-of-the-Art Review.

21. Hypertensive disorders of pregnant women with heart disease: the ESC EORP ROPAC Registry.

23. Canadian Cardiovascular Society 2022 Guidelines for Cardiovascular Interventions in Adults With Congenital Heart Disease.

24. A randomized controlled trial of renin-angiotensin-aldosterone system inhibitor management in patients admitted in hospital with COVID-19.

25. Born to Age: When Adult Congenital Heart Disease Converges With Geroscience.

27. Falling Through the Cracks: The Current Gap in the Health Care Transition of Patients With Kawasaki Disease: A Scientific Statement From the American Heart Association.

28. Neurocognitive disorders amongst patients with congenital heart disease undergoing procedures in childhood.

29. Different levels of care for follow-up of adults with congenital heart disease: a cost analysis scrutinizing the impact on medical costs, hospitalizations, and emergency department visits.

30. Long COVID-19: A Primer for Cardiovascular Health Professionals, on Behalf of the CCS Rapid Response Team.

31. Comparison of Long-term Outcomes of Valve-Sparing and Transannular Patch Procedures for Correction of Tetralogy of Fallot.

33. The 30-Year Outcomes of Tetralogy of Fallot According to Native Anatomy and Genetic Conditions.

34. Lifespan Perspective on Congenital Heart Disease Research: JACC State-of-the-Art Review.

36. Cardiovascular Care Delivery During the Second Wave of COVID-19 in Canada.

37. CHILD-BRIGHT READYorNot Brain-Based Disabilities Trial: protocol of a randomised controlled trial (RCT) investigating the effectiveness of a patient-facing e-health intervention designed to enhance healthcare transition readiness in youth.

38. Discontinuity of Cardiac Follow-Up in Young People With Congenital Heart Disease Transitioning to Adulthood: A Systematic Review and Meta-Analysis.

39. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.

40. Recurrent disease progression networks for modelling risk trajectory of heart failure.

41. Risk prediction models for heart failure admissions in adults with congenital heart disease.

42. Risk of readmission after heart failure hospitalization in older adults with congenital heart disease.

43. Eisenmenger Syndrome in Pregnancy: A Management Conundrum.

44. Creating the BELgian COngenital heart disease database combining administrative and clinical data (BELCODAC): Rationale, design and methodology.

45. Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.

46. Cardiac Rehabilitation During the COVID-19 Era: Guidance on Implementing Virtual Care.

47. Adult Congenital Heart Disease-Preparing for the Changing Work Force Demand.

48. Guiding Cardiac Care During the COVID-19 Pandemic: How Ethics Shapes Our Health System Response.

49. Access and Delivery of Adult Congenital Heart Disease Care in the United States: Quality-Driven Team-Based Care.

50. Determinants of Survival in Older Adults With Congenital Heart Disease Newly Hospitalized for Heart Failure.

Catalog

Books, media, physical & digital resources